Speaker: Anthony V Lemmo, PhD, Chief Operating Officer, BioDot Inc, California, USA
Title: Thinking Big by Being Small: Opportunities and Challenges in “Low Volume” Dispensing
Monday 31 October 2016
12noon to 1pm
Visualisation Studio, H2.G.16 (H2 building), Sippy Downs campus
In this talk I will introduce BioDot's proprietary low volume dispensing technologies. Developed over the past 22 years, BioDot's suite of dispensing technologies enables the research, development and manufacturing of many of the world's leading diagnostic devices and tests. There are many opportunities and challenges in delivering nanoliter and picoliter volumes of fluids. This presentation will present a survey of these opportunities and challenges with highlights from recent case studies.
Anthony V. Lemmo Ph.D., is Chief Operating Officer and acting Vice President of R&D at BioDot Inc..
He joined BioDot in 2006. From 2004 to 2006 Dr. Lemmo was founder and President of Entevis Inc., which was acquired by BioDot in 2006. Entevis designed, manufactured and sold products based on proprietary technology for low mass powder dispensing. From 1999 to 2004 Dr. Lemmo was Director of Technology Development at TransForm Pharmaceuticals. In this role he was a key developer of TransForm’s proprietary platform technologies which were aimed at improving the way pharmaceutical products are developed and optimized.
Prior to TransForm he was Director of Engineering Technology at Cadus Pharmaceuticals from 1998 to 1999 where he was responsible for the development of a novel microscale platform for high throughput screening (HTS). Before Cadus, Dr. Lemmo was a co-founder and Director of Product Applications at Cartesian Technologies from 1996 to 1998. Prior to Cartesian Dr. Lemmo spent 3 years at GlaxoWellcome working in both research and development. Dr. Lemmo has an A.B in chemistry with Honors from the College of the Holy Cross and a Ph.D in analytical chemistry from the University of North Carolina-Chapel Hill. He has authored over 50 publications and presentations and has 10 issued patents and 6 patents pending.